The initial biopsy Gleason score as a predictive marker for docetaxel survival benefit in patients with prostate cancer: Data from the TAX 327 study

被引：4
|
作者：
van Soest, Robert
de Morree, Ellen
Shen, Liji
Tannock, Ian
Eisenberger, Mario A.
De Wit, Ronald
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Sanofi, Malvern, PA USA
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.44
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
44
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study
    Berthold, Dominik R.
    Pond, Gregory R.
    Roessner, Martin
    de Wit, Ronald
    Eisenberger, Mario
    Tannock, Ian F.
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2763 - 2767
  • [32] Low Risk Patients Benefit from Extreme Anterior Apical Sampling on Initial Biopsy for Prostate Cancer Diagnosis
    Elshafei, Ahmed
    Kartha, Ganesh
    Li, Yonghong
    Moussa, Ayman S.
    Hatem, Asmaa
    Gao, Tianming
    Jones, J. Stephen
    PROSTATE, 2014, 74 (12): : 1183 - 1188
  • [33] Reply to Benefit-harm ratio of the diagnostic workup in patients with prostate cancer and a Gleason score of 9 to 10
    Kim, Daniel W.
    Tilki, Derya
    D'Amico, Anthony V.
    CANCER, 2021, 127 (22) : 4312 - 4312
  • [34] The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6-A Study on 320 Patients After Radical Prostatectomy
    Dolejsova, Olga
    Kucera, Radek
    Fuchsova, Radka
    Topolcan, Ondrej
    Svobodova, Hana
    Hes, Ondrej
    Eret, Viktor
    Pecen, Ladislav
    Hora, Milan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17 : 1 - 6
  • [35] The role of PSMA PET/CT in predicting downgrading in patients with Gleason score 4+4 prostate cancer in prostate biopsy
    Aykanat, Ibrahim Can
    Kordan, Yakup
    Seymen, Hulya
    Koseoglu, Ersin
    Ozkan, Arif
    Esen, Baris
    Tarim, Kayhan
    Kulac, Ibrahim
    Falay, Okan
    Gurses, Bengi
    Baydar, Dilek Ertoy
    Canda, Abdullah Erdem
    Balbay, Mevlana Derya
    Demirkol, Mehmet Onur
    Esen, Tarik
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [36] HIGH-RISK PROSTATE CANCER PRESENTING WITH BIOPSY GLEASON SCORE 8, 9 OR 10: DOWNGRADING AND CANCER-SPECIFIC SURVIVAL
    Joniau, Steven
    Spahn, Martin
    Chun, Jongi
    Bastian, Patrick
    Briganti, Alberto
    Tombal, Bertrand
    Marchioro, Giansilvio
    Hsu, Chao-Yu
    Frea, Bruno
    Montorsi, Francesco
    Van Poppel, Hein
    van der Poel, Henk
    Gontero, Paolo
    JOURNAL OF UROLOGY, 2012, 187 (04): : E406 - E406
  • [37] Adverse pathological findings in patients with needle biopsy gleason score 6 prostate cancer following radical prostatectomy
    Bektic, J.
    Pelzer, A. E.
    Schaefer, G.
    Bartsch, G.
    Horninger, W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 281 - 281
  • [38] Magnetic Resonance Imaging-Based Prostate-Specific Antigen Density for Prediction of Gleason Score Upgrade in Patients With Low-Risk Prostate Cancer on Initial Biopsy
    Sim, Ki Choon
    Sung, Deuk Jae
    Kang, Kun Woo
    Yang, Kyung Sook
    Han, Na Yeon
    Park, Beom Jin
    Kim, Min Ju
    Cho, Sung Bum
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2017, 41 (05) : 731 - 736
  • [39] Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa
    Berthold, D. R.
    Pond, G. R.
    de Wit, R.
    Eisenberger, M.
    Tannock, I. F.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1749 - 1753
  • [40] Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam
    Egevad, Lars
    Samaratunga, Hemamali
    Delahunt, Brett
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (04) : 286 - 287
12345